PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma

Watcharin Loilome, Sirinun Juntana, Nisana Namwat, Vajarabhongsa Bhudhisawasdi, Anucha Puapairoj, Banchob Sripa, Masanao Miwa, Hideyuki Saya, Gregory J. Riggins, Puangrat Yongvanit

研究成果: ジャーナルへの寄稿学術論文査読

49 被引用数 (Scopus)


The protein kinase A regulatory subunit 1 alpha (PRKAR1A/PKAI) pathway is overexpressed in varieties of tumors and cancer cell lines including cholangiocarcinoma (CCA), although its role in CCA growth modulation is unclear. In our study, we evaluated the effect of PRKAR1A/PKAI targeting on CCA cell proliferation. Real-time PCR demonstrated an increased mRNA expression of PRKAR1A/PKAI, whereas protein kinase A regulatory subunit 2 beta (PRKAR2B/PKAII) was downregulated in human CCA tissues and CCA cell lines. Immunohistochemistry of human CCA tissues revealed increased PRKAR1A with decreased PRKAR2B protein expression. Moreover, CCA cell lines showed abundantly expressed PRKAR1A, while lacking PRKAR2B expression. Silencing PRKAR1A expression induced growth inhibition and apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases, PI3K/Akt, JAK/STAT and Wnt/β-catenin pathway signaling. The inhibition of PKA using a PKA inhibitor and cAMP analogs also led to a significant cell growth inhibition. In conclusion, our study reports the overexpression as well as molecular mechanisms by which PRKAR1A/PKA regulates human CCA cell growth. Importantly, abrogation of gene expression caused significant CCA cell growth inhibition, oncogenic signaling and coupled apoptosis induction, suggesting PRKAR1A's potential as a drug target for CCA therapy.

ジャーナルInternational Journal of Cancer
出版ステータス出版済み - 01-07-2011

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究


「PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。